Mortality of bullous pemphigoid: an evaluation of 223 patients and comparison with the mortality in the general population in the United States

J Am Acad Dermatol. 2008 Oct;59(4):582-8. doi: 10.1016/j.jaad.2008.07.022. Epub 2008 Aug 15.

Abstract

Background: There are large discrepancies in reported mortality for bullous pemphigoid (BP).

Objective: We sought to determine the mortality of a large cohort of patients with BP and compare this with age-matched control subjects.

Methods: Data were collected on 223 patients with a new diagnosis of BP between 1998 and 2003 through our cutaneous immunofluorescence laboratory databases. The mortality of patients with BP was compared with that of age-matched control subjects in the general US population.

Results: The 1-, 2-, and 5-year mortality was 0.23 (95% confidence interval=0.18, 0.29), 0.37 (95% confidence interval=0.31, 0.44), and 0.50 (95% confidence interval=0.42, 0.57), respectively. However, relative to age-matched control subjects, no difference in expected mortality was detected.

Limitations: This was a retrospective cohort analysis.

Conclusions: Mortality of patients with BP is more likely related to advanced age and associated medical conditions than to disease-specific factors.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Age Distribution
  • Aged
  • Aged, 80 and over
  • Case-Control Studies
  • Cause of Death / trends*
  • Cohort Studies
  • Confidence Intervals
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pemphigoid, Bullous / mortality*
  • Retrospective Studies
  • Sex Distribution
  • Survival Rate
  • United States / epidemiology